-
Molbio Diagnosti
1,393.10 925.80(%) -
Pine Labs
206.10 283.70(%) -
Larsen & Toubro
3,880.55 3,288.65(%) -
HDFC Bank
708.90 1,020.35(%) -
Power Grid Corpn
268.30 250.05(%) -
ESDS Software
1,716.35 1,716.35(%) -
Trent
2,815.00 3,497.35(%) -
Raymond
1,024.00 1,024.00(%) -
Metro Brands
924.20 883.40(%) -
Reliance Industries
1,253.20 1,250.55(%) -
Billionbrains
200.90 227.00(%) -
Ather Energy
1,615.00 530.65(%) -
One 97
1,829.50 1,829.50(%) -
Hind.Aeronautics
4,861.65 3,479.20(%) -
UPL
567.25 558.00(%) -
HDFC Life Insur.
531.15 796.60(%) -
Bajaj Finance
1,015.40 788.40(%) -
Lodha Developers
1,076.00 650.85(%) -
Dhoot Transmission
1,727.35 1,727.35(%) -
Britannia Inds.
4,946.05 4,946.05(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Daikaffil Chemicals India Ltd Chemicals
- Indian Private
- BSE Code : 5255.0
- ISIN : INE789B01018
-
Today’s Low
46.50 -
Today’s High
46.50
-
Open
46.50 -
Perv Close
46.50 -
52W Low
28.48 -
52W High
165.00
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
27.90
-
Div & Yield %
0.00
-
Book Value(₹)
11.23
-
Debt-Equity Ratio
0.00
-
AGM Date
11-Sep-2026
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
27.90
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
6.00
-
BV (₹)
11.20
-
Sales( ₹ in Cr.)
13.35
-
NP (in Cr.)
-2.14
-
NP Var(%)
-19.0
-
Div%
0.0
-
CPS (₹)
-3.00
-
EPS (₹)
-3.60
-
Traded Value (₹ in Lakhs)
27.90
-
52 Week High
165.00
-
52 Week Low
28.48
-
Price BSE
47.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
27.90
-
P/C Ratio
-15.90
-
P/E Ratio
-13.20
-
Price Vs.BV
-3.60
-
10-Jul-2026( 10:08)
Corporate News - Daika... - Daikaffil Chemicals India will...
-
28-May-2026( 05:30)
Results - Announcements - Daika... - Net Loss of Daikaffil Chemical...
-
23-May-2026( 04:51)
Corporate News - Daika... - Daikaffil Chemicals India will...
-
11-Feb-2026( 07:48)
Results - Announcements - Daika... - Net Loss of Daikaffil Chemical...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 13.35 | 7.50 | 0.00 | 0.64 | 8.16 | 11.40 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 13.35 | 7.50 | 0.00 | 0.64 | 8.16 | 11.40 |
| Other Income | 0.05 | 0.47 | 0.71 | 0.41 | 0.47 | 0.55 |
| Stock Adjustments | 0.08 | 0.94 | 0.00 | 0.00 | -0.40 | -0.23 |
| Total Income | 13.48 | 8.91 | 0.71 | 1.05 | 8.23 | 11.72 |
| EXPENDITURE : | ||||||
| Raw Materials | 9.79 | 5.98 | 0.00 | 0.50 | 5.45 | 6.96 |
| Power and Fuel Cost | 1.21 | 0.70 | 0.19 | 0.19 | 0.61 | 0.68 |
| Employee Cost | 2.36 | 1.34 | 1.63 | 1.21 | 2.39 | 2.00 |
| Other Manufacturing Expenses | 0.90 | 1.59 | 0.01 | 0.01 | 0.46 | 0.20 |
| Selling and Administration Expenses | 0.74 | 0.45 | 0.34 | 0.60 | 0.83 | 1.10 |
| Miscellaneous Expenses | 0.29 | 0.17 | 0.09 | 0.07 | 0.05 | 0.07 |
| Employee Benefit Expenses | 2.36 | 1.34 | 1.63 | 1.21 | 2.39 | 2.00 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 15.29 | 10.23 | 2.25 | 2.58 | 9.79 | 11.00 |
| Operating Profit | -1.81 | -1.32 | -1.54 | -1.53 | -1.57 | 0.72 |
| Interest | 0.01 | 0.01 | 0.00 | 0.00 | 0.03 | 0.05 |
| Gross Profit | -1.82 | -1.33 | -1.54 | -1.53 | -1.60 | 0.67 |
| Depreciation | 0.36 | 0.27 | 0.35 | 0.54 | 1.13 | 1.12 |
| Profit Before Tax | -2.18 | -1.60 | -1.89 | -2.07 | -2.73 | -0.45 |
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | 0.03 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.04 | -0.01 | 0.01 | 0.06 | -0.21 | -0.08 |
| Reported Net Profit | -2.14 | -1.59 | -1.90 | -2.13 | -2.50 | -0.41 |
| Extraordinary Items | 0.00 | 0.21 | 0.10 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | -2.14 | -1.80 | -2.00 | -2.13 | -2.50 | -0.41 |
| Adjustment below Net Profit | 0.03 | -0.10 | 0.00 | 0.00 | -0.06 | 0.03 |
| P & L Balance brought forward | 0.49 | 2.17 | 4.07 | 6.21 | 8.79 | 9.17 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -1.63 | 0.49 | 2.17 | 4.07 | 6.23 | 8.79 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -3.57 | -2.65 | -3.17 | -3.56 | -4.17 | -0.68 |
| Earnings Per Share(Adj)-Unit Curr | -3.57 | -2.65 | -3.17 | -3.56 | -4.17 | -0.68 |
| Book Value | 11.23 | 14.75 | 17.56 | 20.73 | 24.33 | 28.60 |
| Book Value(Adj)-Unit Curr | 11.23 | 14.75 | 17.56 | 20.73 | 24.33 | 28.60 |
